132 related articles for article (PubMed ID: 15542674)
1. Replication and pathogenicity of primer binding site mutants of SL3-3 murine leukemia viruses.
Lund AH; Schmidt J; Luz A; Sørensen AB; Duch M; Pedersen FS
J Virol; 1999 Jul; 73(7):6117-22. PubMed ID: 10364369
[TBL] [Abstract][Full Text] [Related]
2. Novel insights into the pathogenesis of the Graffi murine leukemia retrovirus.
Voisin V; Barat C; Hoang T; Rassart E
J Virol; 2006 Apr; 80(8):4026-37. PubMed ID: 16571819
[TBL] [Abstract][Full Text] [Related]
3. MYCT1 inhibits hematopoiesis in diffuse large B-cell lymphoma by suppressing RUNX1 transcription.
Liang Y; Wei X; Yue PJ; Zhang HC; Li ZN; Wang XX; Sun YY; Fu WN
Cell Mol Biol Lett; 2024 Jan; 29(1):5. PubMed ID: 38172714
[TBL] [Abstract][Full Text] [Related]
4. A novel enhancer RNA, Hmrhl, positively regulates its host gene,
Fatima R; Choudhury SR; T R D; Bhaduri U; Rao MRS
Noncoding RNA Res; 2019 Sep; 4(3):96-108. PubMed ID: 31891018
[TBL] [Abstract][Full Text] [Related]
5. Activation of HIV-1 from latent infection via synergy of RUNX1 inhibitor Ro5-3335 and SAHA.
Klase Z; Yedavalli VS; Houzet L; Perkins M; Maldarelli F; Brenchley J; Strebel K; Liu P; Jeang KT
PLoS Pathog; 2014 Mar; 10(3):e1003997. PubMed ID: 24651404
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel erythroid-specific enhancer for the ALAS2 gene and its loss-of-function mutation which is associated with congenital sideroblastic anemia.
Kaneko K; Furuyama K; Fujiwara T; Kobayashi R; Ishida H; Harigae H; Shibahara S
Haematologica; 2014 Feb; 99(2):252-61. PubMed ID: 23935018
[TBL] [Abstract][Full Text] [Related]
7. Cancer gene discovery: exploiting insertional mutagenesis.
Ranzani M; Annunziato S; Adams DJ; Montini E
Mol Cancer Res; 2013 Oct; 11(10):1141-58. PubMed ID: 23928056
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling of murine T-cell lymphoblastic lymphoma identifies deregulation of S-phase initiating genes.
Dabrowska MJ; Ejegod D; Lassen LB; Johnsen HE; Wabl M; Pedersen FS; Dybkær K
Leuk Res; 2013 Oct; 37(10):1383-90. PubMed ID: 23896059
[TBL] [Abstract][Full Text] [Related]
9. A retroviral mutagenesis screen identifies Cd74 as a common insertion site in murine B-lymphomas and reveals the existence of a novel IFNgamma-inducible Cd74 isoform.
Pyrz M; Wang B; Wabl M; Pedersen FS
Mol Cancer; 2010 Apr; 9():86. PubMed ID: 20416035
[TBL] [Abstract][Full Text] [Related]
10. Loss of MicroRNA targets in the 3' untranslated region as a mechanism of retroviral insertional activation of growth factor independence 1.
Dabrowska MJ; Dybkaer K; Johnsen HE; Wang B; Wabl M; Pedersen FS
J Virol; 2009 Aug; 83(16):8051-61. PubMed ID: 19474094
[TBL] [Abstract][Full Text] [Related]
11. Activation of the brain-specific neurogranin gene in murine T-cell lymphomas by proviral insertional mutagenesis.
Nielsen AA; Kjartansdóttir KR; Rasmussen MH; Sørensen AB; Wang B; Wabl M; Pedersen FS
Gene; 2009 Aug; 442(1-2):55-62. PubMed ID: 19376211
[TBL] [Abstract][Full Text] [Related]
12. Control of pathogenicity and disease specificity of a T-lymphomagenic gammaretrovirus by E-box motifs but not by an overlapping glucocorticoid response element.
Ejegod D; Sørensen KD; Mossbrugger I; Quintanilla-Martinez L; Schmidt J; Pedersen FS
J Virol; 2009 Jan; 83(1):336-46. PubMed ID: 18945767
[TBL] [Abstract][Full Text] [Related]
13. Impairment of alternative splice sites defining a novel gammaretroviral exon within gag modifies the oncogenic properties of Akv murine leukemia virus.
Sørensen AB; Lund AH; Kunder S; Quintanilla-Martinez L; Schmidt J; Wang B; Wabl M; Pedersen FS
Retrovirology; 2007 Jul; 4():46. PubMed ID: 17617899
[TBL] [Abstract][Full Text] [Related]
14. The myeloid features of BXH2 leukemias may result from the lack of one copy of the repetitive sequence in the long terminal repeat viral enhancer.
Huang L; Osato M; Yanagida M; Yamashita N; Ito Y
Int J Hematol; 2007 Feb; 85(2):170-2. PubMed ID: 17321997
[No Abstract] [Full Text] [Related]
15. Activation of an oncogenic microRNA cistron by provirus integration.
Wang CL; Wang BB; Bartha G; Li L; Channa N; Klinger M; Killeen N; Wabl M
Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18680-4. PubMed ID: 17121985
[TBL] [Abstract][Full Text] [Related]
16. Importance of receptor usage, Fli1 activation, and mouse strain for the stem cell specificity of 10A1 murine leukemia virus leukemogenicity.
Rodenburg M; Fischer M; Engelmann A; Harbers SO; Ziegler M; Löhler J; Stocking C
J Virol; 2007 Jan; 81(2):732-42. PubMed ID: 17079317
[TBL] [Abstract][Full Text] [Related]
17. A tumor-suppressor function for NFATc3 in T-cell lymphomagenesis by murine leukemia virus.
Glud SZ; Sørensen AB; Andrulis M; Wang B; Kondo E; Jessen R; Krenacs L; Stelkovics E; Wabl M; Serfling E; Palmetshofer A; Pedersen FS
Blood; 2005 Nov; 106(10):3546-52. PubMed ID: 16051745
[TBL] [Abstract][Full Text] [Related]
18. Mutation of all Runx (AML1/core) sites in the enhancer of T-lymphomagenic SL3-3 murine leukemia virus unmasks a significant potential for myeloid leukemia induction and favors enhancer evolution toward induction of other disease patterns.
Sørensen KD; Quintanilla-Martinez L; Kunder S; Schmidt J; Pedersen FS
J Virol; 2004 Dec; 78(23):13216-31. PubMed ID: 15542674
[TBL] [Abstract][Full Text] [Related]
19. Stability of AML1 (core) site enhancer mutations in T lymphomas induced by attenuated SL3-3 murine leukemia virus mutants.
Amtoft HW; Sørensen AB; Bareil C; Schmidt J; Luz A; Pedersen FS
J Virol; 1997 Jul; 71(7):5080-7. PubMed ID: 9188573
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
